Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma

Clinical trial NCT01144988 · UNKNOWN

Trial details

NCT number: NCT01144988
Sponsor: Medical University Innsbruck
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Malignant Glioma

Start date: 2010-03-01
Primary completion: 2013-03-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.